Huntsman Mental Health Institute, Department of Psychiatry, University of Utah, Salt Lake City, UT 84108.
Huntsman Mental Health Institute, Department of Psychiatry, University of Utah, Salt Lake City, UT 84108.
J Bodyw Mov Ther. 2023 Jan;33:176-181. doi: 10.1016/j.jbmt.2022.11.001. Epub 2022 Nov 24.
Generalized Anxiety Disorder (GAD) is a prevalent and costly disorder, and many patients may prefer non-traditional treatment. A proof-of-concept study demonstrated the efficacy of Swedish Massage Therapy (SMT) as a monotherapy for treatment of GAD. Subjects were followed-up 6-12 months after study completion to evaluate post-treatment outcome.
Subjects were enrolled into a randomized, single-masked clinical trial between March of 2012 and May of 2013. Forty-seven untreated subjects with DSM-IV diagnosis of GAD were randomly assigned to 6 weeks of twice-a-week light touch (LT) followed by 6 weeks of twice-a-week SMT, or 12 weeks of twice-a-week SMT. The primary outcome measure was reduction in Hamilton Anxiety Rating Scale (HAM-A) scores after six weeks of SMT versus LT. Qualifying participants received a follow-up survey to investigate whether the benefits of SMT for GAD were sustained.
28 of 40 subjects completed at least 12 sessions of SMT and were sent the follow-up survey. Of the 19 subjects with follow-up, nine (47%) reported no return of GAD symptoms up to 1 year after study completion. There were no differences between those randomized to 12 weeks SMT and those receiving 6 weeks LT followed by 6 weeks SMT. Of those reporting a return of some symptoms, 50% associated symptom return with a stressful life event.
In this first monotherapy trial of SMT for the treatment of GAD, follow-up results suggest that the beneficial effects of SMT may last up to 1 year after end of treatment.
广泛性焦虑障碍(GAD)是一种普遍且代价高昂的疾病,许多患者可能更愿意选择非传统治疗。一项概念验证研究表明,瑞典按摩疗法(SMT)作为 GAD 的单一疗法具有疗效。在研究完成后 6-12 个月对患者进行随访,以评估治疗后的结果。
本研究于 2012 年 3 月至 2013 年 5 月期间采用随机、单盲临床试验,纳入 47 例未经治疗且符合 DSM-IV 诊断标准的 GAD 患者,将其随机分为 6 周,每周 2 次的轻度触摸(LT)治疗组和 6 周,每周 2 次的 SMT 治疗组,或 12 周,每周 2 次的 SMT 治疗组。主要结局指标是 SMT 治疗 6 周后与 LT 相比,汉密尔顿焦虑量表(HAM-A)评分的降低。符合条件的参与者接受了一项随访调查,以调查 SMT 治疗 GAD 的益处是否持续。
40 名患者中有 28 名至少完成了 12 次 SMT 治疗,并收到了随访调查。在 19 名有随访的患者中,9 名(47%)报告称,在研究完成后 1 年内没有出现 GAD 症状的复发。随机分配到 12 周 SMT 组和接受 6 周 LT 治疗后再接受 6 周 SMT 组之间无差异。在报告出现一些症状复发的患者中,50%的患者将症状复发与生活压力事件联系起来。
在 SMT 治疗 GAD 的首次单一疗法试验中,随访结果表明,SMT 的有益效果可能在治疗结束后持续 1 年。